Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2) (Q97046475)
(Redirected from Q97046476)
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Testing Trametinib as a Potential Targeted Treatment in Cancers With GNAQ or GNA11 Genetic Changes (MATCH-Subprotocol S2) |
clinical trial |
Statements
MATCH Treatment Subprotocol S2: Phase II Study of Trametinib in Patients With Tumors With GNAQ or GNA11 Mutations (English)
0 references
25 February 2016
0 references
16 May 2019
0 references
4
0 references
18 year
0 references